In vitro compared activity of telithromycin and azithromycin against northwest Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility

Letters in Applied Microbiology

Volumn 47, Issue 4, 2008, Pages 309-314

  Banche, G ^a   Roana, J ^a   Allizond, V ^a   Andreotti, S ^a   Malabaila, A ^b   Li Vigni, N ^b   Mandras, N ^a   Scalas, D ^a   Tullio, V ^a   Carlone, N A ^a   Savoia, D ^a   Gaido, E ^c   Barbui, A ^c   Cuffini, A M ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b OSPEDALE DEGLI INFERMI   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

Azithromycin; Resistance phenotypes; Streptococcus pneumoniae; Streptococcus pyogenes; Telithromycin

Indexed keywords

METABOLITES;

ANTI-MICROBIAL ACTIVITY; AZITHROMYCIN; IN-VITRO; MACROLIDE RESISTANCE; RESISTANCE PHENOTYPE; S. PYOGENES; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; TELITHROMYCIN; VITRO ACTIVITY;

ANTIBIOTICS;

AZITHROMYCIN; ERYTHROMYCIN; MACROLIDE; TELITHROMYCIN;

ANTIBIOTICS; BACTERIA; HOSPITALS;

ANTIBIOTIC RESISTANCE; ANTIBIOTICS; BACTERIUM; COMPARATIVE STUDY;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; IN VITRO STUDY; ITALY; PHENOTYPE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 52449108047     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/j.1472-765X.2008.02423.x     Document Type: Article

References (30)

1. Barman Balfour, J.A. Figgit, D.P. (2001) Telithromycin. Drugs 61, 815 829.
2. Brown, S.D. Rybak, M.J. (2004) Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study. J Antimicrob Chemother 54, 7 15.
3. Cantón, R., Loza, E., Morosini, M.I. Baquero, F. (2002) Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000. J Antimicrob Chemother 50, 9 24.
4. Catalanotti, P., Catania, M.R., Lucido, M., Martini, S., Gallè, F., Ortega De Luna, L. Rossano, F. (2005) T serotyping and genomic profile of erythromycin-resistant or -sensitive Streptococcus pyogenes isolated in Campania Region, Italy. J Chemother 17, 131 137.
5. Clinical and Laboratory Standards Institute. (2005) Performance Standards for Antimicrobial Susceptibility Testing. Sixteenth Informational Supplement; M100-S16. CLSI, Villanova, PA, USA.
6. Comité de l'Antibiogramme de la Société Française de Microbiologie. Communiqué 2005. http://www.sfm.asso. fr/nouv/general.php?pa=5.
7. Descheemaeker, P., Chapelle, S., Lammens, C., Hauchecorne, M., Wijdooghe, M., Vandamme, P., Ieven, M. Goossens, H. (2000) Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates. J Antimicrob Chemother 45, 167 173.
8. Desjardins, M., Delgaty, K.L., Ramotar, K., Seetaram, C. Toye, B. (2004) Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results. J Clin Microbiol 42, 5620 5623.
9. Drago, L., De Vecchi, E., Nicola, L., Legnani, D. Gismondo, M.R. (2005) Kinetic bactericidal activity of telithromycin, azthromycin and clarithromycin against respiratory pathogens. APMIS 113, 655 663.
10. Farrell, D.J., Morrissey, I., Bakker, S. Felmingham, D. (2002) Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study. J Antimicrob Chemother 50, 39 47.
11. Farrell, D.J., File, T.M. Jenkins, S.G. (2007) Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant Streptococcus pneumoniae over 4 years (2000 to 2004) of the PROTEKT US Study. J Clin Microbiol 45, 290 293.
12. Felmingham, D., Canton, R. Jenkins, S.G. (2007) Regional trends in beta-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001-2004. J Infect 55, 111 118.
13. Giovanetti, E., Montanari, M.P., Mingoia, M. Varaldo, P.E. (1999) Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob Agents Chemother 43, 1935 1940.
14. Giovanetti, E., Montanari, M.P., Marchetti, F. Varaldo, P.E. (2000) In vitro activity of ketolides telithromycin and HMR 3004 against Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility. J Antimicrob Chemother 46, 905 908.
15. Inoue, M., Kaneko, K., Akizawa, K., Fujita, S., Kaku, M., Igari, J., Yamaguchi, K., Kohno, S. et al. (2006) Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-3 (1999-2002). J Infect Chemother 12, 9 21.
16. Ioannidou, S., Tassios, P.T., Zachariadou, L., Salem, Z., Kanelopoulou, M., Kanavaki, S., Chronopoulou, G., Petropoulou, N. et al. (2003) In vitro activity of telithromycin (HMR 3647) against Greek Streptococcus pyogenes and Streptococcus pneumoniae clinical isolates with different macrolide susceptibilities. Clin Microbiol Infect 9, 704 707.
17. Jalava, J., Kataja, J., Seppala, H. Huovinen, P. (2001) In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Antimicrob Agents Chemother 45, 789 793.
18. Jenkins, S.G., Brown, S.D. Farrell, D.J. (2008) Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US years 1-4. Ann Clin Microbiol Antimicrob doi :.
19. Kaneko, T., Romero, K., Li, B. Buzon, R. (2007) Novel tethers in ketolide antibiotics. Bioorg Med Chem Lett 17, 5049 5053.
20. Leclercq, R. (2002) Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 34, 482 492.
21. Malbruny, B., Nagai, K., Coquemont, M., Bozdogan, B., Andrasevic, A.T., Hupkova, H., Leclercq, R. Appelbaum, P.C. (2002) Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations. J Antimicrob Chemother 49, 935 939.
22. Marchese, A. Schito, G.C. (2000) Resistance patterns of lower respiratory tract pathogens in Europe. Int J Antimicrob Agents 16, S25 S29 [review].
23. Mazzariol, A., Koncan, R., Bahar, G. Cornaglia, G. (2007a) Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study. J Chemother 19, 500 507.
24. Mazzariol, A., Koncan, R., Vitali, L.A. Cornaglia, G. (2007b) Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae. J Antimicrob Chemother 59, 1171 1176.
25. Montanari, M.P., Mingoia, M., Giovanetti, E. Varaldo, P.E. (2001) Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci. J Clin Microbiol 39, 1311 1315.
26. Savoia, D., Avanzini, C., Bosio, K., Volpe, G., Carpi, D., Dotti, G. Zucca, M. (2000) Macrolide resistance in group A streptococci. J Antimicrob Chemother 45, 41 47.
27. Shackcloth, J., Williams, L. Farrell, D.J. (2004) Streptococcus pneumoniae and Streptococcus pyogenes isolated from a paediatric population in Great Britain and Ireland: in vitro activity of telithromycin versus comparators. J Infect 48, 229 235.
28. Shibl, A.M. (2005) Patterns of macrolide resistance determinants among S. pyogenes and S. pneumoniae isolates in Saudi Arabia. J Int Med Res 33, 349 355.
29. Waites, K. Brown, S. (2003) Antimicrobial resistance among isolates of respiratory tract infection pathogens from the southern United States: data from the PROTEKT US surveillance program 2000/2001. South Med J 96, 974 985.
30. Zhanel, G.G., Walters, M., Noreddin, A., Vercaigne, L.M., Wierzbowski, A., Embil, J.M., Gin, A.S. Douthwaite, S. (2002) The ketolides: a critical review. Drugs 62, 1771 1804.